CN Stock MarketDetailed Quotes

002100 Tecon Biology Co.Ltd

Watchlist
  • 8.13
  • -0.13-1.57%
Not Open May 31 15:00 CST
11.10BMarket Cap-8566P/E (TTM)

Tecon Biology Co.Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
-31.02%2.68B
-15.00%2.82B
-35.08%3.84B
57.11%3.84B
67.53%3.89B
-3.05%3.32B
96.68%5.92B
37.29%2.45B
24.66%2.32B
65.64%3.42B
Transactional financial assets
--472.63K
-99.93%473.08K
----
--100M
----
--650.94M
----
----
----
----
Notes receivable and accounts receivable
-3.53%712.26M
7.93%430.75M
7.39%817.99M
33.91%731.84M
27.87%738.31M
26.94%399.1M
35.20%761.72M
17.61%546.5M
14.18%577.39M
-3.91%314.39M
-Notes receivable
67.52%26.64M
-11.60%9.62M
654.60%16.46M
306.30%19.82M
6.78%15.9M
30.07%10.88M
-79.03%2.18M
11.89%4.88M
-5.26%14.89M
14.43%8.37M
-Accounts receivable
-5.09%685.63M
8.48%421.13M
5.53%801.54M
31.46%712.02M
28.43%722.41M
26.86%388.22M
37.35%759.54M
17.67%541.62M
14.80%562.5M
-4.33%306.03M
Other receivables (including interest and dividends)
-16.98%256M
-13.60%259.14M
3.05%351.37M
-2.96%301.73M
-17.93%308.36M
-8.72%299.94M
-14.27%340.97M
-18.31%310.92M
-1.42%375.73M
273.51%328.58M
-Other receivable
----
----
----
-2.96%301.73M
----
-8.72%299.94M
----
-18.31%310.92M
----
273.51%328.58M
Advance payment
-27.30%484.52M
-65.96%386.57M
-52.75%372.48M
-23.27%397.31M
-24.24%666.45M
42.71%1.14B
13.60%788.37M
-23.40%517.77M
-31.37%879.64M
-50.00%795.8M
Inventories
-30.13%4.74B
-24.63%4.55B
-17.73%3.24B
-0.22%5.12B
16.73%6.78B
15.07%6.04B
30.87%3.93B
7.45%5.13B
-3.25%5.81B
-12.77%5.25B
Receivable financing
----
397.94%13.53M
----
----
----
1,371.03%2.72M
----
----
----
--184.74K
Other current assets
-19.20%479.93M
-11.04%475.88M
-17.10%333.62M
-4.24%471.21M
14.09%593.93M
7.35%534.95M
44.55%402.43M
35.72%492.07M
2.92%520.59M
-14.45%498.32M
Total current assets
-27.97%9.36B
-27.71%8.96B
-26.23%8.96B
16.21%10.98B
23.87%12.99B
16.81%12.4B
52.71%12.15B
11.36%9.45B
-0.64%10.49B
-0.79%10.61B
Non Current assets
Long-term equity investment
74.83%37.34M
-65.76%36.11M
-70.76%38.84M
-69.39%38.51M
-82.80%21.36M
-2.43%105.45M
10.88%132.83M
10.53%125.8M
14.09%124.16M
3.14%108.07M
Fixed assets
----
----
----
3.70%5.08B
----
18.10%5.13B
----
28.09%4.9B
----
18.24%4.34B
Constru in process
----
----
----
86.76%836.88M
----
-52.47%425.14M
----
-42.20%448.09M
----
65.90%894.54M
Productive biological assets
-22.07%295.55M
-10.65%320.76M
-5.62%363.42M
-17.58%363.08M
-7.13%379.26M
0.79%359M
14.20%385.07M
21.82%440.5M
31.21%408.4M
1.31%356.19M
Intangible assets
40.79%384.78M
34.44%360.84M
22.89%337.17M
22.06%340.96M
-2.63%273.3M
-1.36%268.4M
11.87%274.36M
11.73%279.34M
17.17%280.68M
16.89%272.11M
Development expenditure
-52.15%6.21M
-9.52%7.01M
-82.06%9.06M
-85.09%7.19M
-55.59%12.98M
--7.75M
72.71%50.49M
64.99%48.24M
0.00%29.24M
----
Goodwill
-47.96%178.48M
702.42%178.48M
867.07%215.1M
867.07%215.1M
1,441.92%342.96M
0.00%22.24M
-3.54%22.24M
-3.54%22.24M
--22.24M
--22.24M
Long deferred expense
12.31%23.45M
4.18%24.04M
-3.02%21.88M
-15.07%21.65M
-7.11%20.87M
-11.83%23.08M
-63.49%22.57M
-33.56%25.5M
-71.83%22.47M
-27.75%26.17M
Deferred tax assets
72.12%74.12M
82.53%72.18M
154.77%45.81M
49.64%27.39M
115.31%43.06M
146.29%39.54M
64.94%17.98M
62.78%18.31M
96.32%20M
72.72%16.06M
Usufruct assets
16.12%652.15M
14.91%623.65M
15.81%577.34M
18.20%558.38M
15.15%561.64M
10.90%542.71M
21.81%498.52M
25.61%472.42M
66.92%487.73M
142.03%489.36M
Other non current assets
-99.20%269.78K
-58.77%19.34M
--41.93M
--41.92M
--33.69M
3,561.01%46.9M
----
----
----
-1.52%1.28M
Total non current assets
5.76%7.81B
11.84%7.79B
12.32%7.65B
11.09%7.53B
11.83%7.38B
6.74%6.97B
10.45%6.82B
16.82%6.78B
22.55%6.6B
26.12%6.53B
Total assets
-15.75%17.17B
-13.48%16.75B
-12.38%16.62B
14.07%18.51B
19.22%20.37B
12.97%19.36B
34.25%18.96B
13.58%16.23B
7.20%17.09B
7.98%17.14B
Liabilities
Current liabilities
Short term loan
-16.66%3.18B
3.26%3.32B
-64.90%1.1B
-17.96%2.65B
0.28%3.82B
-19.75%3.21B
18.53%3.15B
51.15%3.23B
4.35%3.81B
-15.91%4.01B
Notes payable and accounts payable
25.42%653.57M
14.07%697.12M
23.17%638.84M
26.31%546.26M
-7.61%521.13M
31.36%611.11M
7.44%518.67M
-13.99%432.48M
38.68%564.08M
-12.17%465.23M
-Notes payable
--21.08M
--5.3M
--8.41M
--4.22M
----
----
----
----
----
----
-Accounts payable
21.37%632.49M
13.21%691.82M
21.55%630.42M
25.33%542.04M
-7.61%521.13M
31.36%611.11M
10.18%518.67M
-11.89%432.48M
57.10%564.08M
10.25%465.23M
Contract liabilities
-1.51%481.41M
-6.82%440.23M
-33.47%346.61M
28.67%736.36M
-35.85%488.79M
-30.64%472.48M
24.38%520.94M
-35.03%572.29M
-17.49%761.99M
13.40%681.16M
Advance receipts
----
-41.79%48.51K
----
----
----
-82.39%83.33K
----
----
----
--473.33K
Salaries payable
-14.11%267.63M
-5.01%297.56M
-12.82%243.63M
-11.12%249.18M
5.14%311.59M
-11.95%313.24M
-5.78%279.45M
-3.05%280.34M
-32.39%296.36M
-26.06%355.77M
Taxs payable
66.33%40.72M
29.09%31.78M
172.86%28.72M
29.46%20.18M
-10.61%24.48M
32.71%24.62M
-57.41%10.53M
-66.18%15.59M
13.00%27.38M
13.79%18.55M
Other payable (including interest and dividends)
-29.92%693.29M
-0.38%731.35M
5.82%769.22M
14.02%760.8M
77.35%989.22M
21.62%734.11M
34.57%726.93M
13.54%667.23M
5.15%557.78M
10.47%603.62M
-Dividend payable
----
----
----
0.00%48.3M
----
-85.94%2.92M
----
-17.42%48.3M
----
--20.78M
-Other payable
----
----
----
15.12%712.5M
----
25.45%731.19M
----
16.97%618.93M
----
7.62%582.84M
Non current liabilities due within one year
57.44%1.71B
104.82%1.49B
277.40%2.27B
102.89%1.53B
93.94%1.08B
-2.00%726.68M
-20.48%602.73M
19.10%752.09M
-27.16%558.66M
126.77%741.55M
Other current liabilities
-15.17%66.01M
-23.21%81.31M
-8.18%60.64M
20.84%80.2M
0.57%77.81M
17.06%105.9M
20.47%66.04M
-4.71%66.37M
-21.73%77.38M
-15.65%90.47M
Total current liabilities
-3.00%7.1B
14.16%7.09B
-7.12%5.47B
8.98%6.57B
8.84%7.32B
-10.95%6.21B
12.52%5.89B
17.15%6.03B
-1.71%6.72B
-5.43%6.97B
Current liabilities
Long term loan
-45.79%1.56B
-60.89%1.23B
-38.60%1.77B
24.82%2.55B
27.68%2.88B
59.52%3.13B
44.20%2.89B
5.58%2.05B
55.99%2.25B
51.78%1.96B
Bonds payable
----
----
----
----
----
----
-4.72%90.71M
-4.55%91.23M
-10.12%92.67M
-9.78%94.62M
Deferred tax liabilities
2,374.31%17.68M
1,150.15%18.13M
4,135.14%16.55M
82.80%714.38K
82.80%714.38K
94.13%1.45M
-13.05%390.8K
-13.05%390.8K
-13.05%390.8K
66.26%747.23K
Long term deferred income
60.50%144.54M
63.74%143.29M
30.71%109.17M
26.18%97.07M
17.40%90.06M
8.01%87.51M
1.46%83.52M
-10.05%76.93M
-12.45%76.71M
-10.32%81.02M
Lease liabilities
27.32%409.42M
19.96%362.93M
26.62%453.64M
6.28%372.97M
-5.91%321.55M
2.70%302.53M
9.88%358.27M
35.03%350.93M
34.40%341.74M
106.43%294.58M
Total non current liabilities
-35.21%2.13B
-50.36%1.75B
-31.23%2.35B
17.89%3.02B
18.98%3.29B
44.75%3.52B
36.46%3.42B
7.82%2.56B
46.29%2.77B
49.17%2.43B
Total liabilities
-13.00%9.23B
-9.20%8.84B
-15.98%7.82B
11.64%9.6B
11.79%10.61B
3.47%9.73B
20.28%9.31B
14.20%8.6B
8.69%9.49B
4.46%9.41B
Shareholders equity
Paid-in capital
0.79%1.37B
0.81%1.37B
0.05%1.36B
0.04%1.35B
0.04%1.35B
0.04%1.35B
25.83%1.35B
25.83%1.35B
25.92%1.35B
25.92%1.35B
Other equity instruments
----
----
-6.48%3.37M
-4.89%3.45M
-4.55%3.52M
-4.47%3.6M
-5.10%3.6M
-4.91%3.63M
-10.48%3.69M
-9.96%3.77M
Capital reserve funds
0.15%3.94B
2.60%3.94B
3.02%3.91B
18.49%3.91B
19.24%3.94B
16.34%3.84B
149.17%3.8B
118.01%3.3B
121.65%3.3B
124.25%3.3B
Surplus reserve funds
6.31%466.77M
6.31%466.77M
58.80%439.08M
58.80%439.08M
58.80%439.08M
59.69%439.08M
21.66%276.49M
21.66%276.49M
21.66%276.49M
20.98%274.95M
Retained profit
-72.26%635.46M
-74.39%581.39M
-42.16%1.43B
-29.79%1.49B
6.50%2.29B
4.72%2.27B
-10.32%2.48B
-33.61%2.12B
-42.68%2.15B
-37.18%2.17B
Other composite income
-115.39%-1.74M
3,494.81%51.12M
120.59%4.52M
160.57%22.52M
112.70%11.27M
115.50%1.42M
-163.54%-21.94M
-332.78%-37.18M
---88.75M
---9.17M
Ordinary risk reserve funds
0.00%3.85M
0.00%3.85M
11.53%3.85M
11.53%3.85M
11.53%3.85M
11.53%3.85M
35.11%3.46M
35.11%3.46M
35.11%3.46M
35.11%3.46M
Shareholders equity without minority interests
-20.25%6.41B
-19.01%6.41B
-9.38%7.15B
2.86%7.23B
14.83%8.04B
11.52%7.92B
40.14%7.89B
16.35%7.03B
6.87%7B
13.87%7.1B
Minority interests
-11.69%1.53B
-12.28%1.5B
-6.76%1.64B
178.21%1.69B
187.09%1.73B
170.08%1.71B
133.61%1.76B
-16.11%607.09M
-9.14%602.61M
0.11%634.88M
Total shareholder equity
-18.73%7.94B
-17.81%7.91B
-8.90%8.8B
16.81%8.92B
28.48%9.77B
24.53%9.63B
51.18%9.66B
12.88%7.63B
5.40%7.6B
12.59%7.73B
Total liabilityies and equity
-15.75%17.17B
-13.48%16.75B
-12.38%16.62B
14.07%18.51B
19.22%20.37B
12.97%19.36B
34.25%18.96B
13.58%16.23B
7.20%17.09B
7.98%17.14B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Sigma Certified Public Accountants (Special General Partnership)
--
--
--
Sigma Certified Public Accountants (Special General Partnership)
--
--
--
Sigma Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds -31.02%2.68B-15.00%2.82B-35.08%3.84B57.11%3.84B67.53%3.89B-3.05%3.32B96.68%5.92B37.29%2.45B24.66%2.32B65.64%3.42B
Transactional financial assets --472.63K-99.93%473.08K------100M------650.94M----------------
Notes receivable and accounts receivable -3.53%712.26M7.93%430.75M7.39%817.99M33.91%731.84M27.87%738.31M26.94%399.1M35.20%761.72M17.61%546.5M14.18%577.39M-3.91%314.39M
-Notes receivable 67.52%26.64M-11.60%9.62M654.60%16.46M306.30%19.82M6.78%15.9M30.07%10.88M-79.03%2.18M11.89%4.88M-5.26%14.89M14.43%8.37M
-Accounts receivable -5.09%685.63M8.48%421.13M5.53%801.54M31.46%712.02M28.43%722.41M26.86%388.22M37.35%759.54M17.67%541.62M14.80%562.5M-4.33%306.03M
Other receivables (including interest and dividends) -16.98%256M-13.60%259.14M3.05%351.37M-2.96%301.73M-17.93%308.36M-8.72%299.94M-14.27%340.97M-18.31%310.92M-1.42%375.73M273.51%328.58M
-Other receivable -------------2.96%301.73M-----8.72%299.94M-----18.31%310.92M----273.51%328.58M
Advance payment -27.30%484.52M-65.96%386.57M-52.75%372.48M-23.27%397.31M-24.24%666.45M42.71%1.14B13.60%788.37M-23.40%517.77M-31.37%879.64M-50.00%795.8M
Inventories -30.13%4.74B-24.63%4.55B-17.73%3.24B-0.22%5.12B16.73%6.78B15.07%6.04B30.87%3.93B7.45%5.13B-3.25%5.81B-12.77%5.25B
Receivable financing ----397.94%13.53M------------1,371.03%2.72M--------------184.74K
Other current assets -19.20%479.93M-11.04%475.88M-17.10%333.62M-4.24%471.21M14.09%593.93M7.35%534.95M44.55%402.43M35.72%492.07M2.92%520.59M-14.45%498.32M
Total current assets -27.97%9.36B-27.71%8.96B-26.23%8.96B16.21%10.98B23.87%12.99B16.81%12.4B52.71%12.15B11.36%9.45B-0.64%10.49B-0.79%10.61B
Non Current assets
Long-term equity investment 74.83%37.34M-65.76%36.11M-70.76%38.84M-69.39%38.51M-82.80%21.36M-2.43%105.45M10.88%132.83M10.53%125.8M14.09%124.16M3.14%108.07M
Fixed assets ------------3.70%5.08B----18.10%5.13B----28.09%4.9B----18.24%4.34B
Constru in process ------------86.76%836.88M-----52.47%425.14M-----42.20%448.09M----65.90%894.54M
Productive biological assets -22.07%295.55M-10.65%320.76M-5.62%363.42M-17.58%363.08M-7.13%379.26M0.79%359M14.20%385.07M21.82%440.5M31.21%408.4M1.31%356.19M
Intangible assets 40.79%384.78M34.44%360.84M22.89%337.17M22.06%340.96M-2.63%273.3M-1.36%268.4M11.87%274.36M11.73%279.34M17.17%280.68M16.89%272.11M
Development expenditure -52.15%6.21M-9.52%7.01M-82.06%9.06M-85.09%7.19M-55.59%12.98M--7.75M72.71%50.49M64.99%48.24M0.00%29.24M----
Goodwill -47.96%178.48M702.42%178.48M867.07%215.1M867.07%215.1M1,441.92%342.96M0.00%22.24M-3.54%22.24M-3.54%22.24M--22.24M--22.24M
Long deferred expense 12.31%23.45M4.18%24.04M-3.02%21.88M-15.07%21.65M-7.11%20.87M-11.83%23.08M-63.49%22.57M-33.56%25.5M-71.83%22.47M-27.75%26.17M
Deferred tax assets 72.12%74.12M82.53%72.18M154.77%45.81M49.64%27.39M115.31%43.06M146.29%39.54M64.94%17.98M62.78%18.31M96.32%20M72.72%16.06M
Usufruct assets 16.12%652.15M14.91%623.65M15.81%577.34M18.20%558.38M15.15%561.64M10.90%542.71M21.81%498.52M25.61%472.42M66.92%487.73M142.03%489.36M
Other non current assets -99.20%269.78K-58.77%19.34M--41.93M--41.92M--33.69M3,561.01%46.9M-------------1.52%1.28M
Total non current assets 5.76%7.81B11.84%7.79B12.32%7.65B11.09%7.53B11.83%7.38B6.74%6.97B10.45%6.82B16.82%6.78B22.55%6.6B26.12%6.53B
Total assets -15.75%17.17B-13.48%16.75B-12.38%16.62B14.07%18.51B19.22%20.37B12.97%19.36B34.25%18.96B13.58%16.23B7.20%17.09B7.98%17.14B
Liabilities
Current liabilities
Short term loan -16.66%3.18B3.26%3.32B-64.90%1.1B-17.96%2.65B0.28%3.82B-19.75%3.21B18.53%3.15B51.15%3.23B4.35%3.81B-15.91%4.01B
Notes payable and accounts payable 25.42%653.57M14.07%697.12M23.17%638.84M26.31%546.26M-7.61%521.13M31.36%611.11M7.44%518.67M-13.99%432.48M38.68%564.08M-12.17%465.23M
-Notes payable --21.08M--5.3M--8.41M--4.22M------------------------
-Accounts payable 21.37%632.49M13.21%691.82M21.55%630.42M25.33%542.04M-7.61%521.13M31.36%611.11M10.18%518.67M-11.89%432.48M57.10%564.08M10.25%465.23M
Contract liabilities -1.51%481.41M-6.82%440.23M-33.47%346.61M28.67%736.36M-35.85%488.79M-30.64%472.48M24.38%520.94M-35.03%572.29M-17.49%761.99M13.40%681.16M
Advance receipts -----41.79%48.51K-------------82.39%83.33K--------------473.33K
Salaries payable -14.11%267.63M-5.01%297.56M-12.82%243.63M-11.12%249.18M5.14%311.59M-11.95%313.24M-5.78%279.45M-3.05%280.34M-32.39%296.36M-26.06%355.77M
Taxs payable 66.33%40.72M29.09%31.78M172.86%28.72M29.46%20.18M-10.61%24.48M32.71%24.62M-57.41%10.53M-66.18%15.59M13.00%27.38M13.79%18.55M
Other payable (including interest and dividends) -29.92%693.29M-0.38%731.35M5.82%769.22M14.02%760.8M77.35%989.22M21.62%734.11M34.57%726.93M13.54%667.23M5.15%557.78M10.47%603.62M
-Dividend payable ------------0.00%48.3M-----85.94%2.92M-----17.42%48.3M------20.78M
-Other payable ------------15.12%712.5M----25.45%731.19M----16.97%618.93M----7.62%582.84M
Non current liabilities due within one year 57.44%1.71B104.82%1.49B277.40%2.27B102.89%1.53B93.94%1.08B-2.00%726.68M-20.48%602.73M19.10%752.09M-27.16%558.66M126.77%741.55M
Other current liabilities -15.17%66.01M-23.21%81.31M-8.18%60.64M20.84%80.2M0.57%77.81M17.06%105.9M20.47%66.04M-4.71%66.37M-21.73%77.38M-15.65%90.47M
Total current liabilities -3.00%7.1B14.16%7.09B-7.12%5.47B8.98%6.57B8.84%7.32B-10.95%6.21B12.52%5.89B17.15%6.03B-1.71%6.72B-5.43%6.97B
Current liabilities
Long term loan -45.79%1.56B-60.89%1.23B-38.60%1.77B24.82%2.55B27.68%2.88B59.52%3.13B44.20%2.89B5.58%2.05B55.99%2.25B51.78%1.96B
Bonds payable -------------------------4.72%90.71M-4.55%91.23M-10.12%92.67M-9.78%94.62M
Deferred tax liabilities 2,374.31%17.68M1,150.15%18.13M4,135.14%16.55M82.80%714.38K82.80%714.38K94.13%1.45M-13.05%390.8K-13.05%390.8K-13.05%390.8K66.26%747.23K
Long term deferred income 60.50%144.54M63.74%143.29M30.71%109.17M26.18%97.07M17.40%90.06M8.01%87.51M1.46%83.52M-10.05%76.93M-12.45%76.71M-10.32%81.02M
Lease liabilities 27.32%409.42M19.96%362.93M26.62%453.64M6.28%372.97M-5.91%321.55M2.70%302.53M9.88%358.27M35.03%350.93M34.40%341.74M106.43%294.58M
Total non current liabilities -35.21%2.13B-50.36%1.75B-31.23%2.35B17.89%3.02B18.98%3.29B44.75%3.52B36.46%3.42B7.82%2.56B46.29%2.77B49.17%2.43B
Total liabilities -13.00%9.23B-9.20%8.84B-15.98%7.82B11.64%9.6B11.79%10.61B3.47%9.73B20.28%9.31B14.20%8.6B8.69%9.49B4.46%9.41B
Shareholders equity
Paid-in capital 0.79%1.37B0.81%1.37B0.05%1.36B0.04%1.35B0.04%1.35B0.04%1.35B25.83%1.35B25.83%1.35B25.92%1.35B25.92%1.35B
Other equity instruments ---------6.48%3.37M-4.89%3.45M-4.55%3.52M-4.47%3.6M-5.10%3.6M-4.91%3.63M-10.48%3.69M-9.96%3.77M
Capital reserve funds 0.15%3.94B2.60%3.94B3.02%3.91B18.49%3.91B19.24%3.94B16.34%3.84B149.17%3.8B118.01%3.3B121.65%3.3B124.25%3.3B
Surplus reserve funds 6.31%466.77M6.31%466.77M58.80%439.08M58.80%439.08M58.80%439.08M59.69%439.08M21.66%276.49M21.66%276.49M21.66%276.49M20.98%274.95M
Retained profit -72.26%635.46M-74.39%581.39M-42.16%1.43B-29.79%1.49B6.50%2.29B4.72%2.27B-10.32%2.48B-33.61%2.12B-42.68%2.15B-37.18%2.17B
Other composite income -115.39%-1.74M3,494.81%51.12M120.59%4.52M160.57%22.52M112.70%11.27M115.50%1.42M-163.54%-21.94M-332.78%-37.18M---88.75M---9.17M
Ordinary risk reserve funds 0.00%3.85M0.00%3.85M11.53%3.85M11.53%3.85M11.53%3.85M11.53%3.85M35.11%3.46M35.11%3.46M35.11%3.46M35.11%3.46M
Shareholders equity without minority interests -20.25%6.41B-19.01%6.41B-9.38%7.15B2.86%7.23B14.83%8.04B11.52%7.92B40.14%7.89B16.35%7.03B6.87%7B13.87%7.1B
Minority interests -11.69%1.53B-12.28%1.5B-6.76%1.64B178.21%1.69B187.09%1.73B170.08%1.71B133.61%1.76B-16.11%607.09M-9.14%602.61M0.11%634.88M
Total shareholder equity -18.73%7.94B-17.81%7.91B-8.90%8.8B16.81%8.92B28.48%9.77B24.53%9.63B51.18%9.66B12.88%7.63B5.40%7.6B12.59%7.73B
Total liabilityies and equity -15.75%17.17B-13.48%16.75B-12.38%16.62B14.07%18.51B19.22%20.37B12.97%19.36B34.25%18.96B13.58%16.23B7.20%17.09B7.98%17.14B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Sigma Certified Public Accountants (Special General Partnership)------Sigma Certified Public Accountants (Special General Partnership)------Sigma Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg